Cinclus Pharma Holding AB (CINPHA.ST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in SEK. Every figure as a table ›

2Y 5Y 10Y All

Quarterly Annual TTM

Operating Income Annual

Net Income Annual

Operating Cash Flow Annual

EPS Annual

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for CINPHA.ST: Revenue, Gross Profit, Cost of Revenue, Free Cash Flow, Shares Outstanding. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.